-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GweUAfpTppyBtz4EICPieG0V4+6m6B56BeiSbqecEH7GwsjjIv+eACAegI3AsZ+s 9wdssB91ikIPWhOI8SFy0w== 0000897101-08-000052.txt : 20080108 0000897101-08-000052.hdr.sgml : 20080108 20080108130026 ACCESSION NUMBER: 0000897101-08-000052 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080108 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20080108 DATE AS OF CHANGE: 20080108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ST JUDE MEDICAL INC CENTRAL INDEX KEY: 0000203077 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411276891 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12441 FILM NUMBER: 08517283 BUSINESS ADDRESS: STREET 1: ONE LILLEHEI PLAZA CITY: ST PAUL STATE: MN ZIP: 55117 BUSINESS PHONE: 6514832000 MAIL ADDRESS: STREET 1: ONE LILLEHEI PLAZA CITY: ST PAUL STATE: MN ZIP: 55117 8-K 1 stjude080085_8k.htm FORM 8-K DATED JANUARY 8, 2008 St. Jude Medical, Inc. Form 8-K dated January 8, 2008

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 8, 2008

 

 

ST. JUDE MEDICAL, INC.

(Exact name of registrant as specified in its charter)

 

Minnesota

0-8672

41-1276891

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)

 

One Lillehei Plaza, St. Paul, MN

55117

(Address of principal executive offices)

(Zip Code)

 

Registrant’s telephone number, including area code: (651) 483-2000

 

Not applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 



Item 7.01   Regulation FD Disclosure.

 

At an investor conference today, St. Jude Medical will announce that it expects to report revenue for the fourth quarter of 2007 of $1.018 billion, representing the Company’s first ever $1 billion quarter and $41 million above the high end of the Company’s guidance. Based on preliminary estimates, the Company believes that approximately $20 million of sales in the fourth quarter are attributable to a competitor’s recall of ICD leads and should be considered a one time event. St. Jude Medical will also announce that it is comfortable with current analysts’ consensus earnings per share expectations in 2008 of $2.09. The Company will announce fourth quarter revenue by product category and earnings results and review its outlook for 2008 during its regularly scheduled earnings call on January 23, 2008.

 





















SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ST. JUDE MEDICAL, INC.


Date:   January 8, 2008

By:   


/s/   Pamela S. Krop

 

Pamela S. Krop
Vice President, General Counsel and Secretary

 

 












 -----END PRIVACY-ENHANCED MESSAGE-----